JP2020537690A5 - - Google Patents

Download PDF

Info

Publication number
JP2020537690A5
JP2020537690A5 JP2020542037A JP2020542037A JP2020537690A5 JP 2020537690 A5 JP2020537690 A5 JP 2020537690A5 JP 2020542037 A JP2020542037 A JP 2020542037A JP 2020542037 A JP2020542037 A JP 2020542037A JP 2020537690 A5 JP2020537690 A5 JP 2020537690A5
Authority
JP
Japan
Prior art keywords
invention described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020542037A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019075216A5 (enExample
JP2020537690A (ja
JP7379347B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/055438 external-priority patent/WO2019075216A1/en
Publication of JP2020537690A publication Critical patent/JP2020537690A/ja
Publication of JP2020537690A5 publication Critical patent/JP2020537690A5/ja
Publication of JPWO2019075216A5 publication Critical patent/JPWO2019075216A5/ja
Priority to JP2023127717A priority Critical patent/JP2023155262A/ja
Application granted granted Critical
Publication of JP7379347B2 publication Critical patent/JP7379347B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020542037A 2017-10-11 2018-10-11 プレクチン1結合抗体およびその使用 Active JP7379347B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023127717A JP2023155262A (ja) 2017-10-11 2023-08-04 プレクチン1結合抗体およびその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762571246P 2017-10-11 2017-10-11
US62/571,246 2017-10-11
PCT/US2018/055438 WO2019075216A1 (en) 2017-10-11 2018-10-11 ANTIBODIES BINDING TO PELTIN-1 AND USES THEREOF

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023127717A Division JP2023155262A (ja) 2017-10-11 2023-08-04 プレクチン1結合抗体およびその使用

Publications (4)

Publication Number Publication Date
JP2020537690A JP2020537690A (ja) 2020-12-24
JP2020537690A5 true JP2020537690A5 (enExample) 2021-11-25
JPWO2019075216A5 JPWO2019075216A5 (enExample) 2022-03-18
JP7379347B2 JP7379347B2 (ja) 2023-11-14

Family

ID=66101714

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020542037A Active JP7379347B2 (ja) 2017-10-11 2018-10-11 プレクチン1結合抗体およびその使用
JP2023127717A Pending JP2023155262A (ja) 2017-10-11 2023-08-04 プレクチン1結合抗体およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023127717A Pending JP2023155262A (ja) 2017-10-11 2023-08-04 プレクチン1結合抗体およびその使用

Country Status (4)

Country Link
US (1) US12053530B2 (enExample)
JP (2) JP7379347B2 (enExample)
CN (1) CN112105380A (enExample)
WO (1) WO2019075216A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017177199A2 (en) 2016-04-08 2017-10-12 Iti Health, Inc. Plectin-1 binding antibodies and uses thereof
CN112105380A (zh) 2017-10-11 2020-12-18 埃缇健康公司D/B/A泽尔拜尔 网蛋白-1结合抗体和其用途
GB202012761D0 (en) * 2020-08-14 2020-09-30 Univ Oxford Brookes Metastatis treatment or prevention
WO2023077099A1 (en) * 2021-10-29 2023-05-04 Zielbio, Inc. Cancer specific plectin-1 specific antibodies and methods of use thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
WO1988001649A1 (en) 1986-09-02 1988-03-10 Genex Corporation Single polypeptide chain binding molecules
US5260203A (en) 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
US7754208B2 (en) 2001-01-17 2010-07-13 Trubion Pharmaceuticals, Inc. Binding domain-immunoglobulin fusion proteins
US7829084B2 (en) * 2001-01-17 2010-11-09 Trubion Pharmaceuticals, Inc. Binding constructs and methods for use thereof
WO2003087768A2 (en) * 2002-04-12 2003-10-23 Mitokor Targets for therapeutic intervention identified in the mitochondrial proteome
US20050164324A1 (en) 2003-06-04 2005-07-28 Gygi Steven P. Systems, methods and kits for characterizing phosphoproteomes
US7842466B1 (en) 2005-09-16 2010-11-30 Celera Corporation Colon disease targets and uses thereof
US20090110680A1 (en) * 2006-04-07 2009-04-30 Stephanie Sieger Combination of an anti ED-B fibronectin domain antibody and gemcitabine
JP2011501731A (ja) 2007-09-10 2011-01-13 ユニバーシティ オブ マサチューセッツ ミトコンドリア標的化抗腫瘍剤
US8147836B2 (en) 2007-12-17 2012-04-03 Dyax Corp. Compositions and methods for treating osteolytic disorders comprising MMP-14 binding proteins
CA2758415C (en) * 2008-04-14 2019-06-04 The General Hospital Corporation Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma
CA2779730C (en) 2009-11-05 2019-04-30 University Of Virginia Patent Foundation Compositions and methods for detecting plectin-1 as a biomarker for cancer
CA2882222A1 (en) * 2012-08-14 2014-02-20 Minerva Biotechnologies Corporation Stem cell enhancing therapeutics
US9856315B2 (en) 2014-10-15 2018-01-02 Cell Signaling Technology, Inc. Methylation and acetylation sites
US10611796B2 (en) * 2016-03-16 2020-04-07 Council Of Scientific & Industrial Research Method for regressing pancreatic tumor by a liposomal formulation along with DNA vaccines
WO2017177199A2 (en) 2016-04-08 2017-10-12 Iti Health, Inc. Plectin-1 binding antibodies and uses thereof
CN112105380A (zh) * 2017-10-11 2020-12-18 埃缇健康公司D/B/A泽尔拜尔 网蛋白-1结合抗体和其用途

Similar Documents

Publication Publication Date Title
JP2019099571A5 (enExample)
JP2019030304A5 (enExample)
JP2021502066A5 (enExample)
JP2020530297A5 (enExample)
JP2020042034A5 (enExample)
JP2022028828A5 (enExample)
JP2022025124A5 (enExample)
JP2021185136A5 (enExample)
JP2021169491A5 (enExample)
JP2019031552A5 (enExample)
JP2018154848A5 (enExample)
JP2020534795A5 (enExample)
JP2021028398A5 (enExample)
JP2020007340A5 (enExample)
JP2020040981A5 (enExample)
JP2019068846A5 (enExample)
JP2021503478A5 (enExample)
JP2021500894A5 (enExample)
JP2021038271A5 (enExample)
JP2020010717A5 (enExample)
JP2016196495A5 (enExample)
JP2017214405A5 (enExample)
JP2018135352A5 (enExample)
JPWO2020148954A5 (enExample)
JP2019142968A5 (enExample)